At a glance
ClinicalIndex Comparison RecordN/ACompleted· 943 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multiple Myeloma Profile in Brazil: A Retrospective Observational Analysis
In Brief
An observational study evaluating No Intervention for Multiple Myeloma. Completed, enrolled 943 participants across 17 sites.
Detailed Summary
The purpose of this study is to present a descriptive analysis of demographic and clinical characteristics of the participants, as well as of the treatment patterns for multiple myeloma (MM) in Brazil.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Myeloma
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 2018
Enrollment StartAug 2018
Primary CompletionNov 2019
Study CompletionJan 2020
TodayJul 2026
First PostedApr 24, 2018
Enrollment StartAug 9, 2018
Primary CompletionNov 8, 2019
Study CompletionJan 27, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.2 years ago
Interventions
No Interventionother
As it was an observational study, no intervention was administered.